Insights into insulin resistance and type 2 diabetes from knockout mouse models

Journal of Clinical Investigation

Volumn 106, Issue 4, 2000, Pages 459-465

  Kadowaki, Takashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE;

ADIPOSE TISSUE; ANIMAL MODEL; DIABETOGENESIS; GENETIC DISORDER; GLUCOSE TRANSPORT; HORMONE ACTION; INSULIN RESISTANCE; KNOCKOUT MOUSE; MOUSE; MUSCLE METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW;

EID: 0033849842     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI10830     Document Type: Review

References (49)

1. Kadowaki, T., et al. 1984. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia. 26:44-49.
2. Taylor, S.I., Accili, D., and Imai, Y. 1994. Insulin resistance or insulin deficiency: which is the primary cause of NIDDM? Diabetes. 43:735-740.
3. Moller, D.E. 1994. Transgenic approaches to the pathogenesis of NIDDM. Diabetes. 43:1394-1401.
4. Rajewsky, K., et al. 1996. Conditional gene targeting. J. Clin. Invest. 98:600-603.
5. Accili, D., et al. 1996. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat. Genet. 12:106-109.
6. Joshi, R.L., et al. 1996. Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. EMBO J. 15:1542-1547.
7. Cinti, S., Eberbach, S., Castellucci, M., and Accili, D. 1998. Lack of insulin receptors affects the formation of white adipose tissue in mice. A morphometric and ultrastructural analysis. Diabetologia. 41:171-177.
8. Brüning, J.C., et al. 1997. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell. 88:561-572.
9. Brüning, J.C., et al. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell. 2:559-569.
10. Wojtaszewski, J.F., et al. 1999. Exercise modulates postreceptor insulin signaling and glucose transport in muscle-specific insulin receptor knockout mice. J. Clin. Invest. 104:1257-1254.
11. Kulkarni, R.N., et al. 1999. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell. 96:329-339.
12. Michael, M.D., et al. 2000. Loss of insulin signalling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell. 6:87-97.
13. Tamemoto, H., et al. 1994. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature. 372:182-186.
14. Araki, E., et al. 1994. Alternative pathway of insulin signaling in mice with targeted disruption of the IRS-1 gene. Nature. 372:186-190.
15. Terauchi, Y., et al. 1997. Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and β cell glucokinase genes: genetic reconstitution of diabetes as a polygenic disease. J. Clin. Invest. 99:861-866.
16. Patti, M.E., et al. 1995. 4PS/Insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice. J. Biol. Chem. 270:24670-24673.
17. Tobe, K., Tamemoto, H., Yamauchi, T., Yazaki, Y., and Kadowaki, T. 1995. Identification of a 190-kDa protein as a novel substrate for the insulin receptor kinase functionally similar to insulin receptor substrate-1. J. Biol. Chem. 270:5698-5701.
18. Sun, X.J., et al. 1995. Role of IRS-2 in insulin and cytokine signalling. Nature. 377:173-177.
19. Yamauchi, T., et al. 1996. Insulin signalling and insulin actions in the muscle and liver of insulin resistant IRS-1 deficient mice. Mol. Cell. Biol. 16:3074-3084.
20. Brüning, J.C., Winnay, J., Cheatham, B., Kahn, R.C. 1997. Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells. Mol. Cell. Biol. 17:1513-1521.
21. Kaburagi, Y., et al. 1997. Role of insulin receptor substrate-1 and pp60 in the regulation of insulin-induced glucose transport and GLUT4 translocation in primary adipocytes. J. Biol. Chem. 272:25839-25844.
22. Lavan, B.E., Lane, W.S., and Lienhard, G.E. 1997. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J. Biol. Chem. 272:11439-11443.
23. Abe, H., et al. 1998. Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. J. Clin. Invest. 101:1784-1788.
24. Withers, D.J., et al. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature. 391:900-904.
25. Kubota, N., et al. 2000. Disruption of insulin receptor substrate-2 causes type 2 diabetes due to liver insulin resistance and lack of compensatory β-cell hyperplasia. Diabetes. In press.
26. Withers, D.J., et al. 1999. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat. Genet. 23:32-40.
27. Liu, S.C., Wang, Q., Lienhard, G.E., and Keller, S.R. 1999. Insulin receptor substrate 3 is not essential for growth or glucose homeostasis. J. Biol. Chem. 274:18093-18099.
28. Terauchi, Y., et al. 1999. Increased insulin sensitivity and hypoglycaemia in mice lacking the p85α subunit of phosphoinositide 3-kinase. Nat. Genet. 21:230-235.
29. Fruman, D.A., Cantley, L.C., and Carpenter, C.L. 1996. Structural organization and alternative splicing of the murine phosphoinositide 3-kinase p85α gene. Genomics. 37:113-121.
30. Katz, E.B., Stenbit, A.E., Hatton, K., DePinho, R., and Charron, M.J. 1995. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature. 377:151-155.
31. Tsao, T.S., et al. 1997. Muscle-specific transgenic complementation of GLUT4-deficient mice. Effects on glucose but not lipid metabolism. J. Clin. Invest. 100:671-677.
32. Stenbit, A.E., et al. 1997. GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nat. Med. 3:1096-1101.
33. Rossetti, L., et al. 1997. Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene. J. Clin. Invest. 100:1831-1839.
34. Tsao, T.S., et al. 1999. Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle. Diabetes. 48:775-782.
35. Zisman, A., et al. 2000. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat. Med. In press.
36. Auwerx, J. 1999. PPARγ, the ultimate thrifty gene. Diabetologia. 42:1033-1049.
37. Okuno, A., et al. 1998. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J. Clin. Invest. 101:1354-1361.
38. Kubota, N., et al. 1999. PPARγ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol. Cell. 4:597-609.
39. Barak, Y., et al. 1999. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol. Cell. 4:585-595.
40. Rosen, E.D., et al. 1999. PPAR gamma is required for the differentiation of adipose tissue in vivo. Mol. Cell. 4:611-617.
41. Miles, P.D., Barak, Y., He, W., Evans, R.M., and Olefsky, J.M. 2000. Improved insulin-sensitivity in mice heterozygous for PPAR gamma deficiency. J. Clin. Invest. 105:287-292.
42. Deeb, S.S., et al. 1998. A Pro 12 Ala substitution in PPARgamma2 associated with decreased receptor activity, low body mass index and improved insulin sensitivity. Nat. Genet. 20:284-287.
43. Hara, K., et al. 2000. A Pro12Ala polymorphism in PPARg2 may confer resistance to type II diabetes. Biochem. Biophys. Res. Commun. 271:212-216.
44. Martin, B.C., et al. 1992. Role of glucose and insulin resistance in the development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet. 340:925-929.
45. Johnston, C., Ward, W.K., Beard, J.C., McKnight, B., and Porte, D., Jr. 1990. Islet function and insulin sensitivity in the non-diabetic offspring of conjugal type 2 diabetic patients. Diabet. Med. 7:119-125.
46. Haffner, S.M., Miettinen, H., Gaskill, S.P., and Stern, M.P. 1995. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes. 44:1386-1391.
47. Cavaghan, M.K., Ehrmann, D.A., and Polonsky, K.S. 2000. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J. Clin. Invest. 106:329-333.
48. Terauchi, Y., et al. 1995. Pancreatic β-cell-specific targeted disruption of glucokinase gene. Diabetes mellitus due to defective insulin secretion to glucose. J. Biol. Chem. 270:30253-30256.
49. Cox, N.J., et al. 1999. Loci on chromosome 2 (NIDDM1) and 15 interact to increase susceptability to diabetes in Mexican Americans. Nat. Genet. 21:213-215.